- Filed
- Jun 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 14, 2024 | 24.69M sh |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $0 |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $2.23M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $2.43M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.71M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $3.92M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $1.79M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $1.73M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $151.07K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $94.61K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $598.65K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $531.12K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.96M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $4.1M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $4.45M |
| Total Assets restated | Q1 2024 · Mar 31, 2023 | $1.61M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 22.94M sh |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.00 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $171.44K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$49.41K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$171.44K |